Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. (Q46856610)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. |
scientific article published in December 2005 |
Statements
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects (English)
Carmelo Blanquicett
M Wasif Saif
Mohamad Eloubeidi
Selwyn M Vickers
David C Chhieng
Mark D Carpenter
Jeffrey C Sellers
Suzanne Russo
Robert B Diasio
Martin R Johnson
1 December 2005